array(1) { [0]=> object(Apache_Solr_Document)#24 (3) { ["_documentBoost":protected]=> bool(false) ["_fields":protected]=> array(6) { ["content_id"]=> array(1) { [0]=> string(13) "DIRECTORY_649" } ["content_title"]=> array(1) { [0]=> string(19) "MARIA CRISTINA BUE'" } ["description"]=> array(1) { [0]=> string(4570) "Inserire qui il curriculumInsert here the curriculum a:5:{i:0;a:14:{s:9:"citazione";s:248:"Pica, F., Gaziano, R., Casalinuovo, I.A., Moroni, G., Buè, C., Limongi, D., et al. (2018). Serum thymosin alpha 1 levels in normal and pathological conditions. EXPERT OPINION ON BIOLOGICAL THERAPY, 18(sup1), 13-21 [10.1080/14712598.2018.1474197].";s:4:"data";s:4:"2018";s:2:"id";s:20:"PUBBLICAZIONE_338264";s:6:"handle";s:11:"2108/204346";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:67:"Serum thymosin alpha 1 levels in normal and pathological conditions";s:9:"metadata6";s:146:"Pica, F; Gaziano, R; Casalinuovo, IA; Moroni, G; Buè, C; Limongi, D; D’Agostini, C; Tomino, C; Perricone, R; Palamara, AT; Sinibaldi, V; P., G";s:9:"metadata7";s:29:"10.1080/14712598.2018.1474197";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:1;a:14:{s:9:"citazione";s:238:"Pica, F., Chimenti, M., Gaziano, R., Bue', M.C., Casalinuovo, I.A., Triggianese, P., et al. (2016). Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 186(1), 39-45.";s:4:"data";s:7:"2016-10";s:2:"id";s:20:"PUBBLICAZIONE_293606";s:6:"handle";s:11:"2108/181622";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:84:"Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases";s:9:"metadata6";s:161:"Pica, F; Chimenti, M; Gaziano, R; Bue', MC; Casalinuovo, IA; Triggianese, P; Conigliaro, P; Di Carlo, D; Cordero, V; Adorno, G; Volpi, A; Perricone, R; Garaci, E";s:9:"metadata7";s:17:"10.1111/cei.12833";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:2;a:14:{s:9:"citazione";s:229:"Moroni, G., Gaziano, R., Buè, C., Agostini, M., Perno, C.F., Sinibaldi-Vallebona, P., et al. (2015). Progesterone and Melanoma Cells: An Old Story Suspended between Life and Death. JOURNAL OF STEROIDS & HORMONAL SCIENCE, 06(03).";s:4:"data";s:10:"2015-08-24";s:2:"id";s:20:"PUBBLICAZIONE_284829";s:6:"handle";s:11:"2108/158017";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:54:"Settore MED/07 - Microbiologia e Microbiologia Clinica";s:9:"metadata4";N;s:9:"metadata5";s:78:"Progesterone and Melanoma Cells: An Old Story Suspended between Life and Death";s:9:"metadata6";s:91:"Moroni, G; Gaziano, R; Buè, C; Agostini, M; Perno, CF; Sinibaldi-Vallebona, P; Pica, F";s:9:"metadata7";s:25:"10.4172/2157-7536.1000158";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:3;a:14:{s:9:"citazione";s:253:"Evangelisti, C., Florian, M.C., Massimi, I., Dominici, C., Giannini, G., Galardi, S., et al. (2009). MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. THE FASEB JOURNAL, 23(12), 4276-4287.";s:4:"data";s:7:"2009-12";s:2:"id";s:19:"PUBBLICAZIONE_32464";s:6:"handle";s:9:"2108/9150";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore BIO/13";s:9:"metadata4";N;s:9:"metadata5";s:113:"MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness";s:9:"metadata6";s:161:"Evangelisti, C; Florian, MC; Massimi, I; Dominici, C; Giannini, G; Galardi, S; Buè, MC; Massalini, S; McDowell, HP; Messi, E; Gulino, A; Farace, MG; Ciafrè, SA";s:9:"metadata7";s:20:"10.1096/fj.09-134965";s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}i:4;a:14:{s:9:"citazione";s:292:"Niola, F., Evangelisti, C., Campagnolo, L., Massalini, S., Buè, M.C., Mangiola, A., et al. (2006). A plasmid-encoded VEGF siRNA reduces glioblastoma angiogenesis and its combination with interleukin-4 blocks tumor growth in a xenograft mouse model. CANCER BIOLOGY & THERAPY, 5(2), 174-9-179.";s:4:"data";s:7:"2006-02";s:2:"id";s:19:"PUBBLICAZIONE_32471";s:6:"handle";s:9:"2108/9180";s:9:"metadata1";s:19:"Articolo su rivista";s:9:"metadata2";N;s:9:"metadata3";s:14:"Settore BIO/13";s:9:"metadata4";N;s:9:"metadata5";s:148:"A plasmid-encoded VEGF siRNA reduces glioblastoma angiogenesis and its combination with interleukin-4 blocks tumor growth in a xenograft mouse model";s:9:"metadata6";s:123:"Niola, F; Evangelisti, C; Campagnolo, L; Massalini, S; Buè, MC; Mangiola, A; Masotti, A; Maira, G; Farace, MG; Ciafrè, SA";s:9:"metadata7";N;s:9:"metadata8";N;s:9:"metadata9";N;s:10:"metadata10";N;}}" } ["meta_keywords"]=> array(1) { [0]=> string(1) "," } ["reserved"]=> array(1) { [0]=> string(1) "0" } ["auth_ip"]=> array(1) { [0]=> string(1) "0" } } ["_fieldBoosts":protected]=> array(6) { ["content_id"]=> bool(false) ["content_title"]=> bool(false) ["description"]=> bool(false) ["meta_keywords"]=> bool(false) ["reserved"]=> bool(false) ["auth_ip"]=> bool(false) } } }